Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Ryo Tanaka

9PUBLICATIONS
20CO-AUTHORS
Psychosocial aspects of childbirth and perinatal mental healthMolecular imaging (incl. electron microscopy and neutron diffraction)AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

Sort by Publication Date:
|Jun 27, 2024
Longitudinal Correlations between Molecular Compositions of Stratum Corneum and Breast Milk Factors during Infancy: A Prospective Birth Cohort Study.

Risa Fukuda, Kyongsun Pak, Megumi Kiuchi

|May 09, 2024
Clinical and laboratory findings characterizing the need for systemic corticosteroids and nonsteroidal systemic therapies and the predicted outcomes in cutaneous polyarteritis nodosa: a single-centre retrospective analysis.

Ryo Tanaka, Keiji Tanese, Yoshihiro Ito

|Nov 22, 2022
Successful management of tumor necrosis factor-α inhibitor-induced erythema multiforme by switching to a Janus kinase inhibitor in a patient with rheumatoid arthritis and ulcerative colitis.

Sakiko Takeuchi, Keitaro Fukuda, Ryo Tanaka

|Oct 05, 2022
Rituximab therapy for intractable pemphigus: A multicenter, open-label, single-arm, prospective study of 20 Japanese patients.

Jun Yamagami, Yuichi Kurihara, Takeru Funakoshi

|Aug 01, 2022
Clinical severity scores as a guide for prediction of initial treatment responses in pemphigus and pemphigoid patients.

Ryo Tanaka, Yuichi Kurihara, Shohei Egami

|Jun 06, 2022
Palmar whitish change after water exposure in a familial mild case of loricrin keratoderma (loricrin ichthyosis).

Sonoko Saito, Ryo Tanaka, Noriko Ono

Pageof 2

Frequent Collaborators

3 joint publications

Yuichi Kurihara

2 joint publications

Keiji Tanese

2 joint publications

Akiko Tanikawa

2 joint publications

Noriko Umegaki-Arao

1 joint publications

Yingyao Zhu

1 joint publications

Sonoko Saito

1 joint publications

Akiharu Kubo

1 joint publications

Jun Yamagami

1 joint publications

Hideyuki Ujiie

1 joint publications

Yoji Hirai

Frequent Collaborators

3 joint publications

Yuichi Kurihara

2 joint publications

Keiji Tanese

2 joint publications

Akiko Tanikawa

2 joint publications

Noriko Umegaki-Arao

Top Related Videos

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of <em>In Vivo</em> Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of <em>In Vivo</em> Upper Airway Immune-mediator Levels

Published on : Aug 07, 2017

10.3K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on : Jul 11, 2013

38.9K
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

1.2K
See more related videos

Top Related Videos

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of <em>In Vivo</em> Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of <em>In Vivo</em> Upper Airway Immune-mediator Levels

Published on : Aug 07, 2017

10.3K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on : Jul 11, 2013

38.9K
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

1.2K
See more related videos